Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "generics"

207 News Found

Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania
News | May 27, 2022

Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania

The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential


Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market
News | May 25, 2022

Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market

The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA


Driving sustainable, enterprise-wide performance acceleration
Opinion | May 19, 2022

Driving sustainable, enterprise-wide performance acceleration

Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time


Premas Biotech appoints Saumen Chakraborty to its Board
People | May 09, 2022

Premas Biotech appoints Saumen Chakraborty to its Board

Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad


Indian pharma growth likely to moderate in FY23: ICRA
News | April 07, 2022

Indian pharma growth likely to moderate in FY23: ICRA

Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23


Dr. Reddy's and MediCane Health launch medical cannabis in Germany
Biotech | April 03, 2022

Dr. Reddy's and MediCane Health launch medical cannabis in Germany

The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021


OPPI summit calls for collaboration across stakeholders
News | March 30, 2022

OPPI summit calls for collaboration across stakeholders

The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India


Pfizer voluntary recall of drugs in the US
News | March 23, 2022

Pfizer voluntary recall of drugs in the US

Voluntary nationwide recall of lots of Accuretic (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets due to n-nitroso- quinapril content


Sanofi moves forward with EUROAPI listing on Euronext Paris
Biotech | March 18, 2022

Sanofi moves forward with EUROAPI listing on Euronext Paris

EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions


Japan tops CPhI ‘API Quality’ ranking for second year
News | March 13, 2022

Japan tops CPhI ‘API Quality’ ranking for second year

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers